Breast cancer is the most common invasive cancer in women worldwide and the incidence has doubled in the last 20 years. Survival rates differ largely, depending on the stage in which a tumor is detected – making early screening so important. Women in low-and middle-income regions are diagnosed at late stages (66%) compared to women in the UK and US (10%) since mammograms are not available. This is why 70% of all breast cancer deaths occur in these regions. To solve this problem iBreast Exam provides breast cancer mass screenings with a handheld breast cancer screening device in the remotest areas of the world.

iBreast exam has the power to change: It is a revolutionary handheld breast cancer screening device with the capability to provide early breast cancer screening. It is the first device that enables workers to identify non-palpable breast lumps fast and painless. iBreast exam has already examined over 400,000 women in over 12 countries. This tool can help to save the lives of many women, especially in low developed countries.